Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey

By sjmartinez • January 17, 2024

Lu Y, Liu Y, Jastreboff AM, Khera R, Ndumele CD, Rodriguez F, Watson KE, Krumholz HM. Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey. Circ Cardiovasc Qual Outcomes. 2024 Jan;17(1):e010640. doi: 10.1161/CIRCOUTCOMES.123.010640. Epub 2023 Nov 11. Erratum in: Circ Cardiovasc Qual Outcomes. 2024 Jan;17(1):e000126. PMID: 37950677; PMCID: PMC10782930.

Tags: adult, Cardiology/Epi, cardiovascular diseases, Ethnicity, Obesity, overweight, Publications

Stress Trajectory and Hypertension 2 to 7 Years After Delivery: A nuMoM2b-HHS Study

Nuckols VR, Barone Gibbs B, Brewer BC, Gaffey AE, Greaney JL, Patterson F, Greenland P, Saade GR, Grobman WA, Yee LM, Bairey Merz CN, Chung[...]

Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease. A scientific statement of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, the ESC Working Group on Adult Congenital Heart Disease, and the Association of Cardiovascular Nursing & Allied Professions of the ESC

D'Alto M, Giannakoulas G, Aboulhosn J, Akagi T, Arvanitaki A, Badagliacca R, Brida M, Bax J, Dimopoulos K, Escribano P, Kjellström B, Mroczek E, Rosenkranz[...]

Calcific Aortopathy in Response to Aging and Injury

Towler DA, Giachelli CM, Scatena M, Tintut Y, Demer LL. Calcific Aortopathy in Response to Aging and Injury. Circulation. 2026 Mar 10;153(10):769-785. doi: 10.1161/CIRCULATIONAHA.125.072393. Epub[...]